| Schedule of Discontinued Operations - Sale of VitaMedica |
| | Years ended June 30, | | | | 2024 | | | 2023 | | Discontinued Operations | | | | | | | Revenue | | $ | 8,707,268 | | | $ | 7,610,949 | | Cost of sales | | $ | 2,051,854 | | | $ | 1,362,036 | | Sales, general and administrative expenses | | $ | 6,076,257 | | | $ | 5,891,301 | | Depreciation and amortization | | $ | 425,263 | | | $ | 527,634 | | Other expenses | | $ | (59,742 | ) | | $ | 212,427 | | Income (loss) from discontinued operations | | $ | 213,636 | | | $ | (382,449 | ) | Accounts receivable net of allowance for doubtful accounts | | $ | - | | | $ | 289,416 | | Fixed assets, net of accumulated depreciation | | $ | - | | | $ | 83,840 | | Total assets | | $ | - | | | $ | 4,875,757 | | Total liabilities | | $ | - | | | $ | | |
|
| Schedule of consideration paid fair value vita medica |
Cash | | $ | 2,100.000 | | Reduction of liabilities | | | 1,900,000 | | Note payable | | | 1,000,000 | | Working capital payment | | | 1,000,000 | | | | $ | 6,000,000 | | | | | | | Recognized amounts of identifiable assets, liabilities and intangible assets transferred: | | | | | | | | | | Cash | | $ | 37,267 | | Accounts receivable | | | 416,374 | | Inventory | | | 1,747,150 | | Prepaid expenses | | | 518,280 | | Fixed assets | | | 111,305 | | Other assets | | | 184,800 | | Liabilities | | | (512,926 | ) | Total identifiable assets | | | 2,502,250 | | Total goodwill and intangible assets | | | 1,549,212 | | Total assets transferred | | | 4,051,462 | | Purchase price | | $ | 6,000,000 | | Gain on sale of VitaMedica | | $ | 1,948,538 | |
|